Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 4.7B | 4.5B | 4.1B | 3.7B |
Cost of revenue | 3B | 2.9B | 2.6B | 2.3B |
Gross profit | 1.7B | 1.6B | 1.6B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 808M | 672M | 705M | 598M |
Operating income | 143M | 350M | 280M | 256M |
Non operating interest income | ||||
Income | 775M | 262M | 141M | 16M |
Expense | 898M | 342M | 172M | 29M |
Other income expense | — | — | — | — |
Pretax income | 166M | 276M | 274M | 265M |
Tax provision | 52M | 52M | 54M | 75M |
Net income | 114M | 224M | 220M | 190M |
Basic EPS | — | 0.8 | 0.8 | 0.7 |
Diluted EPS | — | 0.8 | 0.8 | 0.6 |
Basic average shares | — | 289.3M | 280.3M | 272.8M |
Diluted average shares | — | 289.3M | 280.3M | 292.9M |
EBITDA | 1.3B | 751M | 534M | 362M |
Net income from continuing op. | 166M | 276M | 274M | 265M |
Minority interests | -4M | -7M | -3M | -5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |